Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.


OBJECTIVE To determine the ability of alpha fetoprotein (AFP) and AFP-L3% serum level in discriminating hepatocellular carcinoma (HCC) from other types of liver mass. MATERIAL AND METHOD This study was performed according to a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design. A total of 109 HCC patients and 51 patients with… (More)


  • Presentations referencing similar topics